ARCHIVES

New Grants Awarded In Tobacco Research

This article is from The Cancer Letter archive.

Vol. 04 No. 07 | February 17, 1978

Download PDF Visit The Full Archive

Related Articles

Bevacizumab And Irinotecan May Increase Survival Of GBM

October 26, 2007

Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint

May 31, 2013

President’s Budget Request for FDA Omits Funding for Critical Path.

February 8, 2008

Congress Approves $4.19 Billion For NCI, $23.5 Billion For NIH, In FY2002 Appropriation.

January 4, 2002

Clinical Trials: Institutions Invited By NSABP To Join Raloxifene Trial

July 10, 1998

New Agents, New Approaches Benefit Treatment Of Advanced Lung Cancer

August 29, 2003